CoChat

Formation of a High Affinity Lipid-Binding Intermediate during the Early Aggregation Phase of α-Synuclein

Smith, David P., Tew, Deborah J., Hill, Andrew F., Bottomley, Stephen P., Masters, Colin L., Barnham, Kevin J., Cappai, Roberto · 2008 · Biochemistry
Cited by 66

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The alpha-synuclein (alpha-syn) protein is clearly implicated in Parkinson's disease (PD). Mutations or triplication of the alpha-syn gene leads to early onset PD, possibly by accelerating alpha-syn oligomerization. alpha-syn interacts with lipids, and this membrane binding activity may relate to its toxic activity. To understand how the alpha-syn aggregation state affects its lipid binding activity we used surface plasmon resonance to study the interaction of wild-type and mutant alpha-syn with a charged phospholipid membrane, as a function of its aggregation state. Apparent dissociation constants for alpha-syn indicated that an intermediate species, present during the lag phase of amyloid formation, binds with an increased affinity to the membrane surface. Formation of this species was dependent upon the rate of fibril formation. Fluorescence anisotropy studies indicate that only upon the formation of amyloid material can alpha-syn perturb the acyl-chain region of the lipid bilayer. Circular dichroism spectroscopy showed that upon aging, both wild-type and mutant alpha-syn lose their ability to form lipid-bound alpha-helical species once they become fibrillar. These results indicate that alpha-syn forms a high affinity lipid binding intermediate species during fibril formation. Oligomeric alpha-syn is known to be toxic, and it is feasible that the high affinity binding species described here may correspond to a toxic species involved in PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/bi701522m

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 57

  1. Dauer W., 2003, Neuron 39, 889−909.
  2. Eliezer D., 2001, J. Mol. Biol., 307, 10.1006/jmbi.2001.4538 · DOI · Paper page
  3. Davidson W. S., 1998, J. Biol. Chem., 273, 10.1074/jbc.273.16.9443 · DOI · Paper page
  4. Uversky V. N., 2001, J. Biol. Chem., 276
  5. Weinreb P. H., 1996, Biochemistry 35, 13709−13715.
  6. Der-Sarkissian A., 2003, J. Biol. Chem., 278, 10.1074/jbc.M305266200 · DOI · Paper page
  7. Wood S. J., 1999, J. Biol. Chem., 274
  8. Morris H. R., 2005, Ann. Med., 37, 96, 10.1080/07853890510007269 · DOI
  9. Conway K. A., 2000, Ann. N. Y. Acad. Sci., 920, 45, 10.1111/j.1749-6632.2000.tb06903.x · DOI · Paper page
  10. Conway, K. A., Harper, J. D., and Lansbury, P. T., Jr. (2000) Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid,Biochemistry. 39, 2552−25563. · DOI · Paper page
  11. Greenbaum E. A., 2005, J. Biol. Chem., 280
  12. Conway, K. A., Harper, J. D., and Lansbury, P. T. (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease,Nat. Med.4, 1318−13120. · DOI · Paper page
  13. Tabrizi S. J., 2000, Hum. Mol. Genet. 9, 2683−2689.
  14. Narhi L., 1999, J. Biol. Chem., 274, 10.1074/jbc.274.14.9843 · DOI · Paper page
  15. Conway K. A., 2000, Proc. Natl. Acad. Sci. U.S.A. 97, 571−576.
  16. Bussell R., Jr., 2004, Biochemistry 43, 4810−4818.
  17. Jo E., 2002, J. Mol. Biol., 315
  18. Chandra S., 2003, J. Biol. Chem., 278
  19. Perrin R. J., 2000, J. Biol. Chem., 275, 10.1074/jbc.M004851200 · DOI · Paper page
  20. Dixon C., 2005, Genetics, 170, 59, 10.1534/genetics.104.035493 · DOI · Paper page
  21. Jensen P. H., 1998, J. Biol. Chem., 273
  22. Fortin D. L., 2004, J. Neurosci., 24, 10.1523/JNEUROSCI.1594-04.2004 · DOI · Paper page
  23. Zhu M., 2003, J. Biol. Chem., 278
  24. Cole N. B., 2002, J. Biol. Chem., 277
  25. Cappai R., 2005, FASEB J., 19, 10.1096/fj.04-3437fje · DOI · Paper page
  26. Whitmore L., 2004, Nucleic Acids Res. 32, W668−W673.
  27. Lobley A., 2002, Bioinformatics 18, 211−212.
  28. Smith D. P., 2001, Protein Sci. 10, 1775−1784.
  29. Conway, K. A., Harper, J. D., and Lansbury, P. T., Jr. (2000) Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid,Biochemistry 39, 2552−2563. · DOI · Paper page
  30. Smith A. M., 2006, J. Mol. Biol., 364, 19, 10.1016/j.jmb.2006.08.081 · DOI
  31. Li J., 2001, Biochemistry. 40, 11604−11613.
  32. Kubo S., 2005, J. Biol. Chem., 280, 10.1074/jbc.M504894200 · DOI · Paper page
  33. Jo E., 2000, J. Biol. Chem., 275
  34. Narayanan V., 2001, Biochemistry 40, 9927−9934.
  35. Rhoades E., 2006, Biophys. J., 90, 10.1529/biophysj.105.079251 · DOI · Paper page
  36. Ramakrishnan M., 2006, Biochemistry 45, 3386−3395.
  37. Dahlquist F. W., 1978, Methods Enzymol. 48, 270−299.
  38. Roy M. O., 2001, J. Mol. Recognit., 14, 78
  39. Zhu M., 2003, J. Biol. Chem., 278
  40. Müller W. E., 2001, Biochem. Soc. Trans., 29, 10.1042/bst0290617 · DOI · Paper page
  41. Kamp F., 2006, J. Biol. Chem., 281, 10.1074/jbc.M512292200 · DOI
  42. Li J., 2001, Biochemistry 40, 11604−11613.
  43. Lashuel H. A., 2002, J. Mol. Biol., 322, 10.1016/S0022-2836(02)00735-0 · DOI · Paper page
  44. Volles M. J., 2001, Biochemistry 40, 7812−7819.
  45. Sharon R., 2001, Proc. Natl. Acad. Sci. U.S.A. 98
  46. Zhang B., 1998, Neuron 21, 1465−1475.
  47. Lucke C., 2006, J. Lipid Res., 47
  48. Volles M. J., 2002, Biochemistry 41, 4595−4602.
  49. Hou X., 2005, Biochemistry 44, 11618−11627.
  50. Kaylor J., 2005, J. Mol. Biol., 353, 10.1016/j.jmb.2005.08.046 · DOI · Paper page
  51. Dusa A., 2006, J. Am. Chem. Soc., 48
  52. Krishnan S., 2003, Biochemistry 42, 829−837.
  53. Kayed R., 2004, J. Biol. Chem., 279, 10.1074/jbc.C400260200 · DOI · Paper page
  54. Volles M. J., 2007, J. Mol. Biol., 366, 10.1016/j.jmb.2006.12.044 · DOI · Paper page
  55. Rochet J. C., 2004, J. Mol. Neurosci., 23, 34, 10.1385/JMN:23:1-2:023 · DOI · Paper page
  56. Sharma N., 2006, J. Mol. Neurosci., 28, 10.1385/JMN:28:2:161 · DOI
  57. Abbreviations DPH, diphenyl-1,3,5-hexatriene

Cited by

Metadata

Authors
Smith, D. P., Tew, D. J., Hill, A. F., Bottomley, S. P., Masters, C. L., Barnham, K. J., & Cappai, R.
Venue
Biochemistry
Published
2008-01-08
Volume
47
Issue
5
Pages
1425-1434
ISSN
  • 0006-2960 (ISSN-L)
  • 1520-4995
OpenAlex
W1991335320
Cited by
66
References
1
FWCI
5.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.